Pallidin Antikörper (AA 46-172)
-
- Target Alle Pallidin (PLDN) Antikörper anzeigen
- Pallidin (PLDN) (Pallidin Homolog (PLDN))
-
Bindungsspezifität
- AA 46-172
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Pallidin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Verwendungszweck
- Anti-Human BLOC1S6 Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification.
- Immunogen
- E. coli - derived recombinant Human BLOC1S6 (Asp46-Met172).
- Isotyp
- IgG
- Top Product
- Discover our top product PLDN Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
- Target
- Pallidin (PLDN) (Pallidin Homolog (PLDN))
- Andere Bezeichnung
- BLOC1S6 (PLDN Produkte)
- Hintergrund
- Biogenesis of lysosome-related organelles complex 1 subunit 6, PA, Pallid protein homolog, PLDN, BLOC1S6, Syntaxin 13-interacting protein, Pallidin, BLOC-1 subunit 6
- UniProt
- Q9UL45
- Pathways
- Synaptic Vesicle Exocytosis
-